Di Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Hospital of Hebei Province, Tangshan People's Hospital, TED University, Guangzhou Medical University · ORCID：0000-0002-3371-3344

发表论文 116 篇 · 总被引 1794 次 · h-index 14

代表论文

• Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial (2025 · BMJ · 被引 59)
• Bailout intracranial angioplasty or stenting following thrombectomy for acute large vessel occlusion in China (ANGEL-REBOOT): a multicentre, open-label, blinded-endpoint, randomised controlled trial (2024 · The Lancet Neurology · 被引 55)
• Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial (2025 · The Lancet · 被引 29)
• Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma (2024 · Journal of Hepatocellular Carcinoma · 被引 14)
• Sex-Related Differences in Endovascular Treatment Outcomes for Acute Large Infarcts: The ANGEL-ASPECT Subanalysis (2025 · Stroke · 被引 5)
• Impact of neutrophil‐to‐lymphocyte ratio on the effect of hyperglycemia at admission on clinical outcomes after endovascular thrombectomy (2024 · Neuroprotection/Neuroprotection (Chichester, England. Print) · 被引 5)